Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Total Debt / Equity

Gilead Sciences Inc Total Debt / Equity Chart (GILD)

Gilead Sciences Inc annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Gilead Sciences Inc Total Debt / Equity for the quarter ending September 09, 2020 was $168m a 33.33% increase of 56m year over year
  • Gilead Sciences Inc Total Debt / Equity for the last 12 months ending September 09, 2020 was $168m a 33.33% increase of 56m year over year
  • Gilead Sciences Inc Annual Total Debt / Equity for 2019 was $112m a -13.51% decrease of -15m from 2018
  • Gilead Sciences Inc Annual Total Debt / Equity for 2018 was $127m a -28.95% decrease of -37m from 2017
  • Gilead Sciences Inc Annual Total Debt / Equity for 2017 was $164m a 16.84% increase of 28m from 2016
Other Ratios Metrics:
  • Gilead Sciences Inc Total Debt / Capital for the quarter ending December 12, 2018 was $59m a 1.63% increase of 1m year over year
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
View Chart On Koyfin

Quarterly GILD Total Debt / Equity Data

09/2020$168m
06/2020$133m
03/2020$109m
12/2019$112m
09/2019$122m
06/2019$117m
03/2019$123m
12/2018$127m
09/2018$119m
06/2018$134m

Annual GILD Total Debt / Equity Data

2019$112m
2018$127m
2017$164m
2016$136m
2015$115m
2014$78m
2013$56m
2012$86m
2011$111m
2010$57m